Sunshine Nuohe (688621.SH) has jointly built a collaborative laboratory with the Medical School of Peking University.

Zhixin Finance APP news, Sunshine Nuohe (688621.SH) announced that in order to implement the national science and technology development policy, enhance independent innovation capabilities and national core competitiveness, promote the quality and efficiency of innovation research and development work, the company will cooperate with the medical school of Peking University to jointly establish the "Peking University Medical-Sunshine Nuohe Innovation Drug Joint Laboratory." The two parties will focus on cutting-edge fields such as cell therapy, gene therapy, and develop clinical candidate drugs as the core goal, fully leveraging their respective strengths, and collaboratively promote the high-quality development of the company in the field of innovative drug research and development.